Seelos Therapeutics, Inc. Cash
Seelos Therapeutics, Inc. had Cash of $294.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2024-08-14
- 2024-06-30: Cash $294.00K.
- 2024-03-31: Cash $524.00K.
- 2023-12-31: Cash $3.00M.
- 2023-09-30: Cash $2.58M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2024-06-30 | $294.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $524.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.00M 10-Q · filed 2024-08-14 | |
| 2023-09-30 | $2.58M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $5.84M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $14.06M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $15.53M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $30.51M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $41.25M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $61.77M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $78.73M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $76.83M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $87.20M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $38.69M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $15.66M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $8.05M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $5.85M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $12.69M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $10.26M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $15.31M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $9.73M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $11.29M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $42.00K 10-K · filed 2020-03-17 | $3.58M 10-K · filed 2019-03-28 |
| 2018-09-30 | $5.28M 10-Q · filed 2018-10-31 | |
| 2017-12-31 | $6.33M 10-K · filed 2019-03-28 | |
| 2011-09-30 | $8.88M 10-Q · filed 2011-11-14 | |
| 2010-12-31 | $9.15M 10-Q · filed 2011-11-14 |